Talisay, Royswel .

HRN: 24-68-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2024
CEFUROXIME 1.5GM (VIAL)
03/07/2024
03/07/2024
IV
1.5grams
OD
EX LAP
Waiting Final Action 
03/07/2024
CEFUROXIME 1.5GM (VIAL)
03/07/2024
03/14/2024
IV
1.5g
Q8
S/P Pelvic Lap
Waiting Final Action 
03/08/2024
CEFUROXIME 500MG (TAB)
03/08/2024
03/14/2024
PO
1 Tab
BID
SP Pelvic Laparotomy With Right Salpingectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: